HB944

Mississippi HB944 extends and codifies the repealer on the prohibition against health plans requiring step therapy for certain cancer drugs.

Mississippi HB944 amends the state code to extend and codify the repealer on the prohibition against health benefit plans requiring step therapy or fail-first protocols for certain prescription drugs used to treat advanced, metastatic cancer and associated conditions. The bill allows for an override of these protocols if the prescribing practitioner can demonstrate that the required treatment is ineffective or likely to cause harm. The provisions of the bill apply to drugs approved by the FDA and supported by evidence-based literature.